Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2026-03-05 @ 3:42 PM
Study NCT ID:
NCT00370851
Status:
COMPLETED
Last Update Posted:
2009-11-25
First Post:
2006-08-31
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Intravitreal Bevasizumab VS Sham Treatment in Acute BRVO: A Randomized Clinical Trial
Sponsor:
Shahid Beheshti University of Medical Sciences
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
8532
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None